Showing results (1-10 of 8,416) with videos related to
Sort By:
Pageof 842
Anticancer Research|May 1, 1988
DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicinS Ando, K Kamiya, T Yoshimura, et al.Nihon Gan Chiryo Gakkai Shi|May 20, 1990
[Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues]M Uchida, K Kamiya, T Yoshimura, et al.Leukemia Research|January 1, 1991
Pharmacological studies of retinol palmitate and its clinical effect in patients with acute non-lymphocytic leukemiaH Tsutani, T Ueda, M Uchida, et al.Nihon Gan Chiryo Gakkai Shi|July 20, 1990
[Studies on intracellular kinetics of ara-C triphosphate in HL-60, human leukemia cells in relation to reasonable administration of ara-C]K Kamiya, M Uchida, T Ueda, et al.Nihon Gan Chiryo Gakkai Shi|January 20, 1990
[Clinical effect and pharmacokinetics of intermediate dose Ara-C therapy in a patient with acute non-lymphocytic leukemia with two CNS recurrences]T Fukushima, T Ueda, K Kamiya, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1990
[Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia (IPL) accompanied with severe thrombocytopenia and interstitial pneumonitis]H Tsutani, K Kamiya, N Domae, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1991
[Fulminant hepatitis cured by plasma exchange in a patient with acute leukemia--a case report]H Iwasaki, T Ueda, K Inai, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|December 1, 1996
[Characteristic features of gouty patients]T Nakamura, H Tsutani, T UedaLeukemia Research|January 1, 1990
Reduction of leukemia cell growth in a patient with acute promyelocytic leukemia treated by retinol palmitateH Tsutani, H Iwasaki, Y Kawai, et al.Cancer Research|January 1, 1994
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosineT Ueda, K Kamiya, Y Urasaki, et al.Pageof 842